Development of the COVID-19 Stigma Perception Scale

Elif Kant; Reva Balcı Akpınar; Gülay İpekçoban

Makale detayları

Development of the COVID-19 Stigma Perception Scale

Yazarlar:

Elif Kant | Reva Balcı Akpınar | Gülay İpekçoban

Yayıncı:

Ataturk University

Ana Başlıklar:

Health Services and Systems (Other)

Dergi:

Journal of Midwifery and Health Sciences Vol.7 Issue 3, pp.495-505

Belge Tipi:

Makale

Yayın Tarihi:

10/2024

Belge Dili:

İngilizce

Document ID (Org No.):

2001329346

pISSN:

2687-2110

Anahtar kelimeler:

Özet:

 Objective: The aim of this study is to develop a valid and reliable measurement tool to be used to determine the stigma perception experienced by individuals with COVID-19 during the disease process. Methods: The study was conducted in the methodological research type. The data of the study were collected with the draft COVID-19 Stigma Perception Scale developed by the researchers between March and June 2021. The study included 316 individuals who had COVID-19 disease. Results: Explanatory and Confirmatory factor analysis was used to evaluate the scales factor structure, yielding a 3-dimensional structure that explained 47.76 per cent of the overall variation. The compatibility values of the scale were found as X2Sd 2.17, RMSEA .060, SRMR.05, NFI .80, CFI  .90, GFI .85, AGFI .80 and TLI  .90. Internal consistency, two-half reliability analyses, and item analyses were conducted to be able to determine the reliability of the scale, as a result of which adequacy was attained for the reliability of the scale. Conclusion: As a result of this research, it has been determined that and 37-item scale developed to evaluate the perception of COVID-19 stigma is both a valid and reliable measurement tool. This scale should be tested and used for different languages and cultures.

 Objective: The aim of this study is to develop a valid and reliable measurement tool to be used to determine the stigma perception experienced by individuals with COVID-19 during the disease process. Methods: The study was conducted in the methodological research type. The data of the study were collected with the draft COVID-19 Stigma Perception Scale developed by the researchers between March and June 2021. The study included 316 individuals who had COVID-19 disease. Results: Explanatory and Confirmatory factor analysis was used to evaluate the scales factor structure, yielding a 3-dimensional structure that explained 47.76 per cent of the overall variation. The compatibility values of the scale were found as X2Sd 2.17, RMSEA .060, SRMR.05, NFI .80, CFI  .90, GFI .85, AGFI .80 and TLI  .90. Internal consistency, two-half reliability analyses, and item analyses were conducted to be able to determine the reliability of the scale, as a result of which adequacy was attained for the reliability of the scale. Conclusion: As a result of this research, it has been determined that and 37-item scale developed to evaluate the perception of COVID-19 stigma is both a valid and reliable measurement tool. This scale should be tested and used for different languages and cultures.

 Objective: The aim of this study is to develop a valid and reliable measurement tool to be used to determine the stigma perception experienced by individuals with COVID-19 during the disease process. Methods: The study was conducted in the methodological research type. The data of the study were collected with the draft COVID-19 Stigma Perception Scale developed by the researchers between March and June 2021. The study included 316 individuals who had COVID-19 disease. Results: Explanatory and Confirmatory factor analysis was used to evaluate the scales factor structure, yielding a 3-dimensional structure that explained 47.76 per cent of the overall variation. The compatibility values of the scale were found as X2Sd 2.17, RMSEA .060, SRMR.05, NFI .80, CFI  .90, GFI .85, AGFI .80 and TLI  .90. Internal consistency, two-half reliability analyses, and item analyses were conducted to be able to determine the reliability of the scale, as a result of which adequacy was attained for the reliability of the scale. Conclusion: As a result of this research, it has been determined that and 37-item scale developed to evaluate the perception of COVID-19 stigma is both a valid and reliable measurement tool. This scale should be tested and used for different languages and cultures.

 Amaç: Bu çalışmanın amacı, COVID-19lu bireylerin hastalık sürecinde yaşadıkları damgalanma algısını belirlemek için kullanılabilecek geçerli ve güvenilir bir ölçüm aracı geliştirmektir. Yöntem: Araştırma metodolojik araştırma türünde yürütülmüştür. Araştırmanın verileri araştırmacılar tarafından Mart-Haziran 2021 tarihleri arasında geliştirilen taslak COVID-19 Damgalanma Algısı Ölçeği ile toplanmıştır. Çalışmaya COVID-19 hastalığını geçirmiş 316 birey dahil edilmiştir. Bulgular: Ölçeğin faktör yapısını değerlendirmek için Açıklayıcı ve Doğrulayıcı faktör analizi kullanılarak toplam varyasyonun yüzde 47,76sını açıklayan 3 boyutlu bir yapı elde edilmiştir. Ölçeğin uyum indeks değerleri X2Sd 2,17, RMSEA .060, SRMR.05, NFI .80, CFI  .90, GFI .85, AGFI .80 ve TLI  .90 olarak bulunmuştur. Ölçeğin güvenirliğini belirlemek amacıyla iç tutarlılık, iki yarı güvenirlik analizleri ve madde analizleri yapılmış ve bunun sonucunda ölçeğin güvenirliği açısından yeterliliğe ulaşılmıştır. Sonuç: Bu araştırma sonucunda, COVID-19 damgalanma algısını değerlendirmek amacıyla geliştirilen 37 maddelik bu ölçeğin hem geçerli hem de güvenilir bir ölçme aracı olduğu tespit edilmiştir. Bu ölçeğin farklı dil ve kültürler için test edilmesi ve kullanılması gerekmektedir.

Makale detayları

Development of the COVID-19 Stigma Perception Scale

Yazarlar:

Elif Kant | Reva Balcı Akpınar | Gülay İpekçoban

Yayıncı:

Ataturk University

Ana Başlıklar:

Health Services and Systems (Other)

Dergi:

Journal of Midwifery and Health Sciences Vol.7 Issue 3, pp.495-505

Belge Tipi:

Makale

Yayın Tarihi:

10/2024

Belge Dili:

İngilizce

Document ID (Org No.):

2001329346

pISSN:

2687-2110

COVID-19

Stigma

Scale Development

Factor AnalysisCOVİD-19

Damgalanma

Ölçek Geliştirme

Faktör Analizi

Sayı

Makale detayları

Yazarlar: Elif Kant | Reva Balcı Akpınar | Gülay İpekçoban

Yayıncı: Ataturk University

Ana Başlıklar: Health Services and Systems (Other)

Dergi: Journal of Midwifery and Health Sciences Vol.7 Issue 3, pp.495-505

Belge Tipi: Makale

Yayın Tarihi: 10/2024

Belge Dili: İngilizce

Document ID (Org No.): 2001329346

pISSN: 2687-2110

Sayı

Yazarlar:

Elif Kant | Reva Balcı Akpınar | Gülay İpekçoban

Yayıncı:

Ataturk University

Ana Başlıklar:

Health Services and Systems (Other)

Dergi:

Journal of Midwifery and Health Sciences Vol.7 Issue 3, pp.495-505

Belge Tipi:

Makale

Yayın Tarihi:

10/2024

Belge Dili:

İngilizce

Document ID (Org No.):

2001329346

pISSN:

2687-2110